Clinical Trials
3 trialsNCT01397799 2015-12-07
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Athenex, Inc.
Phase 1 Completed
NCT00658970 2011-06-08
Evaluation of KX2-391 in Patients With Advanced Malignancies
Athenex, Inc.
Phase 1 Completed
NCT00646139 2011-03-02
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
Roswell Park Cancer Institute
Phase 1 Completed